Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 19/20 | 0.58 |
| ▸ | NPM1 | P06748 | 12/20 | 0.58 |
| ▸ | INSR | P06213 | 11/20 | 0.58 |
| ▸ | JAK2 | O60674 | 3/20 | 0.50 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL520907 | 0.89 | ALK (0.72) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL520516 | 0.85 | ALK (0.77) | ALKNPM1INSRJAK2KCNH2 | |
| SCHEMBL2511041 | 0.85 | ALK (0.58) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL2527491 | 0.83 | ALK (0.56) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL2522445 | 0.82 | ALK (0.61) | ALKNPM1INSRJAK2KCNH2 | |
| SCHEMBL522459 | 0.82 | ALK (0.73) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL520190 | 0.81 | ALK (0.68) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL2522168 | 0.80 | ALK (0.59) | ALKNPM1INSRJAK2PTK2 | |
| SCHEMBL521545 | 0.79 | ALK (0.79) | ALKNPM1INSRJAK2KCNH2 | |
| SCHEMBL2507023 | 0.79 | ALK (0.51) | ALKNPM1INSRJAK2PTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376491-A1 | PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS | Cephalon, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010071885-A1 | PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS | CEPHALON, INC. (US) | 2010-06-24 | — | — | WO | disclosed |